Carregant...
Treatment With Metoprolol Succinate, a Selective Beta Adrenergic Blocker, Lowers Blood Pressure Without Altering Insulin Sensitivity in Diabetic Patients
Insulin resistance is a risk factor for cardiovascular disease. Therapies to lower blood pressure should not decrease insulin sensitivity, especially among high‐risk patients such as diabetics. This study examined the effect of the β1‐selective adrenergic receptor‐blocking agent extended‐release met...
Guardat en:
| Publicat a: | J Clin Hypertens (Greenwich) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Blackwell Publishing Inc
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8110087/ https://ncbi.nlm.nih.gov/pubmed/18174771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2007.07458.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|